TP53 and prostate carcinoma: As the associated factors of EAF2, such as hypoxia-induced factor 1α (HIF-1α), PTEN, von Hippel–Lindau protein (pVHL), and p53, were identified in sequence, the network of the downstream pathways of EAF2 in prostate cancer would be gradually completed.